article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

The selections feature topics ranging from a review of the regulatory consequences of the FDA’s accelerated approval of eteplirsen, to a comparison of the safety and effectiveness of generic and brand-name fluticasone-salmeterol for COPD, to an analysis of free speech challenges to Medicare drug price negotiation under the Inflation Reduction Act.

article thumbnail

DIR Reform: what you need to know

Natalia Mazina

Many pharmacy and patient advocacy groups have spoken out against the obscure methods employed by PBMs to increase their profits. These groups have advocated for the fees to be applied at the time a patient picks up the medication at the pharmacy rather than subjecting pharmacies to these fees months later.

Medicare 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California pharmacies will no longer be required to pay back the state under its new reimbursement methodology

Natalia Mazina

Several pharmacists and patient advocacy groups filed legal actions against the DHCS and worked with legislature to eliminate these chargebacks to pharmacies. This lead to overpayments to pharmacies.

article thumbnail

Heart Health at #CES2019 – Food and Tech as Medicine

Health Populi

An important example of this self-care approach is the evidence-based Ornish food regimen which is reimbursed by Medicare (as a form of cardiac rehabilitation). Using food and tech as medicine can help people avoid going on medications like statins and others for heart health.

FDA 72
article thumbnail

Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program

CMS.gov

Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program. They are concrete quality topics which reflect core issues that are most vital to high quality care and better patient outcomes. Jeremy.Booth@c…. Fri, 03/02/2018 - 16:30. Kate Goodrich, M.D.,

article thumbnail

CMS Finalizes Major Changes to Hospital Price Transparency Rule

Hall Render

The Centers for Medicare & Medicaid Services (“CMS”) finalized significant updates to the Hospital Price Transparency regulation for the first time since the rule took effect on January 1, 2021.

article thumbnail

How Patient Movement Benefits from Standardized Acuity Scoring

HIT Consultant

More than a decade ago, CMS established the Continuity Assessment Record and Evaluation (CARE) set to measure the health and functional status of Medicare beneficiaries at the time of discharge and/or admission in post-acute care settings.

Nurses 52